RecruitingACTRN12605000181606

Counselling to reduce anxiety and depressive symptoms in women with a new diagnosis of gynaecological cancer.


Sponsor

Dr Rodney Petersen

Enrollment

200 participants

Start Date

Mar 1, 2004

Study Type

Interventional

Conditions


Eligibility

Sex: Females

Plain Language Summary

Simplified for easier understanding

This study looks at whether counselling (talking therapy) can reduce anxiety and depression in women who have recently been diagnosed with gynaecological cancer (such as cervical, ovarian, or uterine cancer). A cancer diagnosis can be emotionally overwhelming, and researchers want to find out whether structured counselling support makes a meaningful difference. You may be eligible if: - You are a woman with a new diagnosis of a gynaecological cancer - You have not previously been diagnosed with cancer - You do not have a previous or current history of psychiatric illness - Your score on the Hospital Anxiety and Depression Scale (HADS) is above 5 at the time of enrolment You may NOT be eligible if: - There are no specific exclusion criteria listed for this study Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The intervention consists of three Solution Focused Therapy counselling sessions conducted by a research nurse immediately post operatively. Follow up consists of 6 weeks and 4 month questionnaires (H

The intervention consists of three Solution Focused Therapy counselling sessions conducted by a research nurse immediately post operatively. Follow up consists of 6 weeks and 4 month questionnaires (HADS, SWLS, Brief COPE and Yale Brown single item tool).


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000181606